99
Views
4
CrossRef citations to date
0
Altmetric
Short Report

Predictors of COVID-19 Hospital Treatment Outcome

, , &
Pages 10247-10256 | Published online: 22 Dec 2021

Figures & data

Figure 1 The scheme of Naive Bayes model building process.

Figure 1 The scheme of Naive Bayes model building process.

Table 1 Mean (x) and Confidence Intervals (5%, 95%) at a = 0.05, for C-Reactive Protein (CRP) [mg/L], Procalcitonin (PCT) [ng/mL], Fibrinogen (Fg) [g/L] and D-dimers [ng/mL], Immature Globulins (IG) [%], and Interleukin 6 (IL-6) [pg/mL] Stratified by Survival Status

Figure 2 Age distribution differences between the survived and deceased subjects.

Figure 2 Age distribution differences between the survived and deceased subjects.

Figure 3 Histogram of CRP levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 3 Histogram of CRP levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 4 Histogram of PCT levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 4 Histogram of PCT levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 5 Histogram of Fibrinogen levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 5 Histogram of Fibrinogen levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 6 Histogram of D-dimers levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 6 Histogram of D-dimers levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 7 Histogram of IG% levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 7 Histogram of IG% levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 8 Histogram of IL6 levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.

Figure 8 Histogram of IL6 levels distribution in (A) subjects who survived COVID-19 infection, (B) deceased subjects, and (C) comparison of differences in means between survived and deceased subjects. * - denotes P < 0.05.